Fate Therapeutics (FATE) Receivables (2015 - 2026)
Fate Therapeutics' Receivables came in at $703,000 for Q2 2026, down 49.6% from $1.4 million a year earlier and down 0.1% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Receivables (2015 - 2026) Analysis & Trends
At the end of FY2025, Fate Therapeutics' Receivables was $916,000, down 74.1% from FY2024.
- Receivables carries a five-year compound annual growth rate of -30.2% (FY2020 to FY2025).
- Going back by year, Receivables was $3.54 million in FY2024 (+93.8%), $1.83 million in FY2023 (-95.3%), $38.48 million in FY2022 (+343.5%) and $8.68 million in FY2021 (+57.3%).
- The five-year range for quarterly Receivables is $682,000 (Q3 2025) to $38.48 million (Q4 2022).
- Year-over-year, Receivables has declined for four consecutive quarters, with growth averaging 24.7% over the last eight quarters.
- The fastest year-over-year change in Receivables over five years came in Q4 2022 (growth of 343.5%), and the weakest in Q4 2023 (a decline of 95.3%).
- Business Quant data shows FATE's Receivables at $704,000 (Q1 2026), $916,000 (Q4 2025) and $682,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Fate Therapeutics | 248.02 Mn | 94.22 Mn | - | 703,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 703,000.00 |
| Mar 31, 2026 | 704,000.00 |
| Dec 31, 2025 | 916,000.00 |
| Sep 30, 2025 | 682,000.00 |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 858,000.00 |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 2.83 Mn |
| Mar 31, 2023 | 13.50 Mn |
| Dec 31, 2022 | 38.48 Mn |
| Sep 30, 2022 | 10.22 Mn |
| Jun 30, 2022 | 13.13 Mn |
| Mar 31, 2022 | 13.85 Mn |
| Dec 31, 2021 | 8.68 Mn |
| Sep 30, 2021 | 7.31 Mn |
API Access
Fate Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();